Trial Profile
Comparison of Different Treatment Regimens in Patients With Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2014
Price :
$35
*
At a glance
- Drugs Charcoal (Primary) ; Lactulose
- Indications Hepatic encephalopathy
- Focus Therapeutic Use
- Sponsors Ocera Therapeutics
- 25 May 2014 New trial record